Is COL2A1 p.Pro740His (c.2219C>A) pathogenic?

COL2A1 p.Pro740His (c.2219C>A) is classified Conflicting classifications of pathogenicity in COL2A1 (ClinVar, Conflicting submitters, 2 submitters; last evaluated 2026-05-20). AlphaMissense: likely benign (0.128); Very rare (popmax 0.000848%, nfe).

How common is COL2A1 p.Pro740His (c.2219C>A) in the general population?

COL2A1 p.Pro740His (c.2219C>A) is very rare (popmax 0.000848%, nfe) (gnomAD).

What do computational predictors say about COL2A1 p.Pro740His (c.2219C>A)?

AlphaMissense predicts likely benign (score 0.128) — an in-silico prediction, not a clinical call.

COL2A1 p.Pro740His

c.2219C>A · rs774819000 · VCV1063765

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 2 submitters

AlphaMissense

likely benign

0.128 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.000848%, nfe)

Missense predictors

1/2 damaging

AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense	0.128	likely benign
REVEL	0.403	indeterminate
SaProt	LLR -11.85	damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 9.5	GERP 1.9, phastCons 1
Regional constraint	o/e 0.62	unconstrained · MANE · 21 kb · p 2.4e-45 · regional, not allelic
Overall
CADD	23.4	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.000848% European (non-Finnish) · 10/1,179,592 alleles

Filtering AF 0.000429% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000313%

Overall 0.000744% 12/1,612,986 alleles · very rare

Ancestry group	Frequency	1 in
Remaining individualsnot grpmax-eligible	0.0032%	31,221
European (non-Finnish)grpmax	0.000848%	117,959

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: COL2A1
Protein: p.Pro740His
Coding: c.2219C>A
MANE Select: NM_001844
dbSNP: rs774819000
Type: single nucleotide variant
Location: chr12:47982584 (GRCh38)
Gene constraint: LOEUF 0.183 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 53.56 · 11 PDB
Residue 740: the 'disordered' region; the 'triple-helical region' region

Full COL2A1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

COL2A1 p.Pro740Ala Uncertain significance ★ ⚠ same residue
COL2A1 p.Pro740Arg Uncertain significance ★ ⚠ same residue
COL2A1 p.Pro740Leu Uncertain significance ★ ⚠ same residue
COL2A1 p.Pro740Ser Uncertain significance ★ ⚠ same residue
COL2A1 p.Pro740= Likely benign ★ same residue
COL2A1 p.Pro740fs Pathogenic ★★ same residue
COL2A1 c.1023+1G>A Pathogenic ★★ same type
COL2A1 c.1024-2A>C Pathogenic ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/col2a1-p-pro740his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown